BioPharma Credit PLC (MUN:B3P)

BioPharma Credit Revenue

BioPharma Credit had revenue of $83.78M USD in the half year ending June 30, 2025, with 6.70% growth. This brings the company's revenue in the last twelve months to $154.66M, up 13.42% year-over-year. In the year 2024, BioPharma Credit had annual revenue of $150.03M with 10.53% growth.

• Revenue (ttm): $154.66M
• Revenue Growth: +13.42%
• P/S Ratio: 6.67
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 878.24M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	150.03M	14.29M	10.53%
Dec 31, 2023	135.74M	-82.43M	-37.78%
Dec 31, 2022	218.17M	114.29M	110.02%
Dec 31, 2021	103.88M	-6.14M	-5.58%
Dec 31, 2020	110.02M	-40.89M	-27.09%